Literature DB >> 22016418

Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma.

Yao-Tseng Chen1, Rita Chiu, Peishan Lee, Debra Beneck, Boquan Jin, Lloyd J Old.   

Abstract

BACKGROUND: Cancer/testis (CT) antigens are cancer antigens normally expressed in adult testicular germ cells. The expression of chromosome X-encoded CT antigens (CT-X antigens) in human fetal gonads and in testicular seminomas was examined.
METHODS: The expression of 10 CT-X antigens (MAGEA, NY-ESO-1, GAGE, CT7/MAGEC1, CT10/MAGEC2, CT45, SAGE1, SSX2, NXF2 and SPANX) was studied immunohistochemically.
RESULTS: In adult human testis, SPANX is expressed in late spermatids and spermatozoa, whereas all other CT-X antigens are predominantly expressed in spermatogonia or primary spermatocytes. All CT-X antigens except SPANX are expressed in human fetal germ cells. CT-X-positive germ cells appear as early as 13 weeks after gestation, increase with age and reach a plateau at around 22 weeks. In the fetal ovary, CT-X-positive oogonia are most abundant at around 24 weeks and sharply decrease subsequently. CT-X antigens are almost exclusively expressed in OCT3/4-negative gonocytes and their expression appears to coincide with the loss of pluripotency. Spermatocytic seminoma, a neoplasm derived from adult pre-meiotic germ cells, showed uniform expression of all CT-X antigens except SPANX. In contrast, most seminomas (>80%) express CT7, CT45, GAGE and CT10 but express MAGEA, NXF2 and NY-ESO-1 at lower frequency, and very rarely express SSX2 and SAGE1.
CONCLUSIONS: Most CT-X antigens are expressed in human fetal germ cells after they have lost stem cell characteristics, with predominant expression in pre-meiotic germ cells. Spermatocytic seminomas showed expression of all CT-X antigens except SPANX, whereas classical seminomas only express some CT-X antigens, reflecting their different origins from adult versus fetal germ cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22016418     DOI: 10.1093/humrep/der330

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  18 in total

1.  Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.

Authors:  Jessica A Hemminger; Amanda Ewart Toland; Thomas J Scharschmidt; Joel L Mayerson; Denis C Guttridge; O Hans Iwenofu
Journal:  Mod Pathol       Date:  2014-01-24       Impact factor: 7.842

2.  Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.

Authors:  Liang Han; Bin Jiang; Hao Wu; Shu Zhang; Xueguan Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Cancer testis antigen expression in testicular germ cell tumors and in intratubular germ cell neoplasia.

Authors:  Yao-Tseng Chen
Journal:  Mod Pathol       Date:  2015-05       Impact factor: 7.842

4.  Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas.

Authors:  Yao-Tseng Chen; Dengfeng Cao; Rita Chiu; Peishan Lee
Journal:  Cancer Immun       Date:  2013-05-10

5.  Cancer-Testis Antigen LDH-C4 in Tissue, Serum, and Serum-Derived Exosomes Serves as a Promising Biomarker in Lung Adenocarcinoma.

Authors:  Wei Peng; Jin Chen; Yanping Xiao; Guangjian Su; Yan Chen; Zhaolei Cui
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

6.  Limited expression of cancer-testis antigens in renal cell carcinoma patients.

Authors:  Norihito Soga; Yasuhide Hori; Koichiro Yamakado; Hiroaki Ikeda; Naoko Imai; Shinichi Kageyama; Kazunori Nakase; Atsushi Yuta; Norio Hayashi; Hiroshi Shiku; Yoshiki Sugimura
Journal:  Mol Clin Oncol       Date:  2012-11-19

7.  Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors.

Authors:  Martin A Rijlaarsdam; David M J Tax; Ad J M Gillis; Lambert C J Dorssers; Devin C Koestler; Jeroen de Ridder; Leendert H J Looijenga
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

8.  MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.

Authors:  Fan Yang; Xingchun Zhou; Xia Miao; Tao Zhang; Xiaojun Hang; Ru Tie; Nan Liu; Fei Tian; Fuli Wang; Jianlin Yuan
Journal:  Breast Cancer Res Treat       Date:  2014-04-01       Impact factor: 4.872

9.  CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers.

Authors:  John J Kim; Krithika Rajagopalan; Basil Hussain; Brenten H Williams; Prakash Kulkarni; Steven M Mooney
Journal:  Biomark Res       Date:  2013-06-13

10.  Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition.

Authors:  Sinem Yilmaz-Ozcan; Asli Sade; Baris Kucukkaraduman; Yasemin Kaygusuz; Kerem Mert Senses; Sreeparna Banerjee; Ali Osmay Gure
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.